专利检索 ap:("Luoxin Pharmaceutical (Shanghai) Co., Ltd." OR "Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.") AND inv:"WU, Chengde" 第 1 页

1.

发明公开
QUINAZOLINONE COMPOUND AND APPLICATION THEREOF 审中-公开

公开(公告)号：EP3712143A1

公开(公告)日：2020-09-23

申请号：EP18876913.7

申请日：2018-11-12

申请人： Luoxin Pharmaceutical (Shanghai) Co., Ltd. , Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.

发明人： WU, Chengde , HUANG, Jingjie , YU, Tao , DONG, Jiaqiang , WANG, Tie-Lin , LI, Jie , LI, Jian , CHEN, Shuhui

IPC分类号： C07D401/04 , C07D401/14 , C07D417/14 , C07D409/14 , C07D405/14 , A61K31/517 , A61P35/00

摘要： The present invention relates to a series of quinazolinone compounds and applications thereof as PI3Kα inhibitors. In particular, the present invention relates to a compound shown in formula (I) and a tautomer or pharmaceutically acceptable salt thereof.